Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
69.8 HKD | -4.32% | -1.97% | -20.14% |
06:04pm | London stocks take hit as Wall Street slips | AN |
05:54pm | London stocks take hit as Wall Street slips | AN |
Summary
- On the basis of various fundamental qualitative criteria, the company appears to be particularly poorly ranked from a medium and long-term investment perspective.
- From a short-term investment perspective, the company presents a deteriorated fundamental configuration.
Strengths
- The company's attractive earnings multiples are brought to light by a P/E ratio at 10.69 for the current year.
- Analysts have a positive opinion on this stock. Average consensus recommends overweighting or purchasing the stock.
- The average target price set by analysts covering the stock is above current prices and offers a tremendous appreciation potential.
Weaknesses
- For the last twelve months, the trend in sales revisions has been clearly going down, which emphasizes downgraded expectations from the analysts.
- The company's sales previsions for the coming years have been revised downwards, which foreshadows another slowdown in business.
- For the last 12 months, analysts have been regularly downgrading their EPS expectations. Analysts predict worse results for the company against their predictions a year ago.
- For the last few months, analysts have been revising downwards their earnings forecast.
- The average price target of analysts who are interested in the stock has been significantly revised downwards over the last four months.
- The price targets of various analysts who make up the consensus differ significantly. This reflects different assessments and/or a difficulty in valuing the company.
- The company's earnings releases usually do not meet expectations.
Ratings chart - Surperformance
Sector: Life & Health Insurance
1st Jan change | Capi. | Investor Rating | ESG Refinitiv | |
---|---|---|---|---|
-20.14% | 25.5B | - | ||
+10.00% | 80.6B | B- | ||
+7.80% | 51.13B | B+ | ||
+1.47% | 48.65B | B | ||
+9.72% | 42.58B | B+ | ||
+6.42% | 40.23B | B+ | ||
+19.86% | 38.14B | B | ||
+2.24% | 30.09B | B | ||
-7.50% | 27.79B | B- | ||
+10.38% | 22.87B | A |
Financials
Valuation
Momentum
Consensus
Business Predictability
Technical analysis
- Stock Market
- Equities
- PRU Stock
- 2378 Stock
- Ratings Prudential plc